EssilorLuxottica: Sight To Behold - [Business Breakdowns, EP.210]

Summary

• EssilorLuxottica is a €26.5bn-revenue “consumer health company where none of its brands actually had the honor of making it to the company name” — the only player spanning eyewear’s full chain from prescription lenses through frames, sunglasses, and retail. Revenue splits 75/25 vision care vs. frames/sunglasses; its vision-care side is three times the size of closest competitor Alcon; and its 550m lenses made last year could provide glasses for just over 5% of the world’s population — against an expectation that by 2050 five billion people, half the planet, will be shortsighted.
• Guest Swetha Ramachandran’s pricing-power verdict: moderate, not monopolistic. Gross margins of 63-64% sit above Nike/Adidas’s 50s but far below luxury’s 80%+, and “it’s not the case that you’re being gouged because you have to buy a pair of Ray-Bans — there are perfectly respectable and serviceable substitutes.” Lenses are an almost-oligopoly (~55% share vs. Hoya and Carl Zeiss); frames/sunglasses are just over a third, with roughly 40% of that market fragmented.
• She thinks management’s 19-20% EBIT-margin target by end FY26 is likely to be delayed. About half of the 63% gross margin is consumed by selling expense across ~18,000 stores and 200,000 employees, leaving a 16% EBIT margin (€3.5bn); her view is that investment in growth, potentially including smart glasses and hearing technology, comes first. Tariffs are “a potential spanner in the works,” and “I’m really not sure that that 20% target… may necessarily be achievable given the complexity of operating this business.”
• Smart glasses could redefine the TAM — but EssilorLuxottica doesn’t own the critical technology. Ray-Ban Meta launched in October 2023, and the company recently said it had sold 2m units at a “surprisingly affordable” ~$300. Ramachandran thinks they are building capacity to sell up to 10m units; their apparent “if you build it, they will come” approach is intended to increase adoption before competition arrives. Smartwatches are a ~$34bn market versus ~$3bn for smart glasses. But first mover may not win — Apple and other players such as Sesame could compete, and “it’ll only be as successful as Meta AI itself is successful.”
• The $1.5bn Supreme acquisition from VF Corp (2024, less than VF paid) has, in her view, “been given a free pass” since the smart-glasses phenomenon took off. Her read: Supreme skews Asian, younger, and Gen Z — a possible brand vehicle for smart glasses in that demographic — but “if it was just to sell hats and T-shirts… I’m really not sure this was the best use of one and a half billion dollars of shareholder money.” Nuance Audio’s hearing solution in glasses form could retail for ~$1,500 and is being launched over the counter in the U.S. and through audiologists in Europe.
• She sees Warby Parker as perhaps now “more of a me-too player rather than a true disruptor.” Its own-the-experience, outsource-manufacturing model thrived in the pandemic but has “struggled to turn a profit” against EL’s 16% EBIT margins, and its sales sit at ~2% of EssilorLuxottica’s; post-pandemic consumers “voted with their feet” for multibrand choice. She does not dismiss antitrust claims but sees limited evidence for them: 33% frames share, competitor brands sold in its own stores, and Hoya and Kering Eyewear simultaneously rivals and major customers.
• The durable lessons: family control can enable Arnault-style patience, and vertical integration is “the key to unlocking value” in low-margin categories. Del Vecchio revived a left-for-dead Ray-Ban (bought for $640m in 1999) into a $3bn+ revenue powerhouse over 15 years, walked away from Safilo in 2009 when the math failed, and persevered from early Google Glass attempts and Ray-Ban Stories to Meta Ray-Ban. The caveat from the 2018-21 boardroom war: “don’t air your dirty laundry in public.”

Deep dive

1. A consumer-health giant with no namesake brand — and a penetration runway measured in billions

• Ramachandran’s opener reframes the company: “a consumer health company where none of its brands actually had the honor of making it to the company name” — there is no brand called Essilor or Luxottica, yet Ray-Ban, Oakley, and now Supreme are more recognizable than the parent. It’s the only company spanning the full spectrum from prescription lenses to frames and sunglasses, skewing 75/25 toward vision care, and three times the size of closest competitor Alcon on the vision-care side.
• Her back-of-envelope on penetration: €26.5bn of sales, 550m prescription lenses made last year — enough to provide glasses for just over 5% of the world’s population — and at a roughly €200 average spend, perhaps even a generous assumption, maybe 113m consumers a year. Set against 2bn+ people touched by myopia and five billion shortsighted by 2050, with child myopia particularly high in China and India, “relative penetration… should continue to increase.”
• The structural kicker: vision impairment is “one of the world’s most untreated and undiagnosed disabilities” — at the bottom of the income pyramid in developing economies, roughly 90% of cases are undiagnosed — and uncorrected impairment costs the global economy north of $300 billion in lost productivity.

2. Del Vecchio’s vertical-integration bet, and the boardroom brawl it survived

• The 2018 merger married “innovation meeting iconization”: Essilor was the first manufacturer of the progressive lens, Varilux, in 1959, followed by further innovations and M&A such as Transitions; Luxottica could “take these dusty forgotten brands like Ray-Ban and really reignite and catalyze growth.” Del Vecchio’s conviction that controlling every step of the value chain unlocks value drove the deal — “it turns out that he was right,” with 12,000+ patents and end-to-end operations to show for it.
• The governance saga 2018-21 — worth keeping as a cautionary tale: imagined as a merger of equals with a three-year power-sharing arrangement, it descended into public warfare — Del Vecchio, whose Delfin holding owns just over 32% economically, accused Mr. Sagnières of a power grab; the counter-charge was that Del Vecchio was trying to execute a zero-premium merger. Arbitration and a settlement produced a co-CEO structure: Francesco Milleri as official CEO, with Essilor deputy CEO Paul du Saillant also in place. It was “quite damaging… for morale, definitely the share price.”
• Mid-battle, July 2019, they still bought GrandVision: a €7bn+ deal against a ~€50bn market cap at a similar P/E — “a hugely dilutive deal” — with the European Commission requiring concessions and remedies, including the sale of 350 stores across Belgium, Italy, and the Netherlands. But it gave Essilor what it never had: direct-to-consumer distribution instead of reliance on third-party wholesalers.

3. Pricing power is moderate — the market structure explains why

• The two markets are structurally different: prescription lenses are almost an oligopoly (EL ~55% share, then Hoya and Carl Zeiss), while frames/sunglasses are brand-led and fragmented — EL just over a third, Kering Eyewear ~10%, Safilo ~7%. The fragmented tail is only 3% of the lens market but roughly 40% of frames and sunglasses.
• Her gross-margin test for pricing power: 63-64%, stable for five years since the merger, above Nike/Adidas in the 50s but nowhere near luxury’s 80%+ — and management isn’t guiding to material uplift. Against the “$1 of plastic marked up to $200” criticism: “it’s not the case that you’re being gouged because you have to buy a pair of Ray-Bans — there are perfectly respectable and serviceable substitutes.”
• On cyclicality, the split holds up in crises: lenses are a necessity for 4bn+ people, with some eye exams covered by insurance or employer benefits; standalone Essilor kept growing through the GFC, while sunglasses fell by a moderate mid-single digit amount — possibly an affordable-luxury “lipstick effect,” as Leonard Lauder called it.

4. Where the 63% gross margin goes — and why 20% EBIT may slip

• About half the gross margin is selling expense — 18,000 retail stores and close to 200,000 employees — leaving a 16% EBIT margin (€3.5bn). R&D is only 2% of sales yet the company spends roughly 3-4 times as much as the industry; advertising runs 7%; and G&A at ~8% is, in her words, “a little bit of general admin bloat, if I may.”
• Her call on the FY26 target of 19-20% EBIT margin: “likely to be delayed, because their first priority will be to invest in growth” — smart glasses and Nuance adoption are potential reinvestment areas, and tariffs loom as “a potential spanner in the works of their margin ambition.”
• Capex peaked at ~7% of sales, with steady-state capex expected at ~5%: a third into operations, a third into retail, and ~20% into digital — with e-commerce now 7% of sales and “increasingly table stakes.”

5. Smart glasses redefine the TAM — but the partnership model is untested ground

• Ray-Ban Meta is “really the only connected-glasses option to reach mass-market adoption”: launched in October 2023, it had reportedly sold 2m units by the time of the conversation. Ramachandran thinks EssilorLuxottica is building capacity to sell up to 10m units, priced surprisingly affordably at about $300 — an “if you build it, they will come” approach intended to increase adoption before competition arrives. The prize: smartwatches are a ~$34bn market versus ~$3bn for smart glasses. Meta said it had approval to take a 5% stake — but has not confirmed whether it did so — and both sides are “quite cagey” on economics.
• Her caution — this is unlike anything EL has done before: “they don’t own this technology, they don’t own Meta AI functionality… it’ll only be as successful as Meta AI itself is successful.” Apple could arrive with superior functionality; she also flags other players, including a voice assistant called Sesame that makes apparently highly rated AI glasses, as evidence the space will be “quite competitive.”
• Supreme ($1.5bn from VF Corp in 2024, less than VF paid) “has somehow been given a free pass” since the smart-glasses phenomenon: her thesis is Supreme — skewing Asian, younger, and Gen Z — becomes the brand vehicle to popularize smart glasses in that demographic, as Ray-Ban and Oakley do for somewhat older consumers and developed markets. Otherwise: “if it was just to sell hats and T-shirts… I’m really not sure this was the best use of one and a half billion dollars of shareholder money.” Nuance Audio’s hearing solution in glasses form could retail for about $1,500; the product is about to be or is in the process of being launched over the counter in the U.S. and through audiologists in Europe, addressing mild-to-moderate hearing loss while “minimizing the stigma.”

6. The moat is open-architecture scale — Warby wasn’t the disruptor, and antitrust looks thin

• The Warby Parker verdict: the DTC model that owned the customer experience and outsourced manufacturing was a pandemic-era success but has “struggled to turn a profit” against EL’s 16% EBIT margins; its sales sit at ~2% of EL’s, and its single-brand focus became a weakness as consumers “voted with their feet” for choice. Ramachandran says it is perhaps now “more of a me-too player rather than a true disruptor.”
• The unusual moat feature is open architecture: unlike Inditex, EL’s competitors are also its customers — Hoya is one of its big customers, and Kering Eyewear’s Gucci sunglasses sell through its stores — “you would never find something from H&M in a Zara store.” That structure is relevant to antitrust: EL has 33% of frames and sunglasses, sells competitor products in its own stores, and — while she does not dismiss the claims entirely — anyone browsing an airport sunglass store can see “no company really has dominance or pricing power in this category.” For potentially differentiated products such as Stellest and Nuance, she argues that innovation could carry a premium, in a pharma-like way.
• Her closing lessons: family control gets “a bad rap” in Europe but can enable Del Vecchio’s Arnault-like horizon — Ray-Ban, left for dead at Bausch & Lomb, became a $3bn+ revenue powerhouse over 15 years — paired with discipline (walking away from Safilo in 2009) and perseverance through early Google Glass attempts and Ray-Ban Stories 1.0, which did not take off. Vertical integration “is the key to unlocking value” where Nike and Adidas’ post-pandemic attempts to go completely DTC and forgo wholesale ended badly — margins have roughly doubled to 16% in seven-odd years. And finally: “don’t air your dirty laundry in public.”